Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Seacrown is a China-based medical device company focused on contrast medium injection systems used in diagnostic imaging. The company develops, manufactures, and sells power injectors and related consumables for CT, MRI, and DSA applications, including single-head and dual-head injector systems. Publicly available distributor and marketplace materials describe Seacrown as an early domestic Chinese developer of dual CT injectors and MRI injectors, with a patent portfolio and a global installed base. Its business appears to be centered on commercialized imaging hardware rather than therapeutics, making it a healthcare equipment manufacturer rather than a biotech or drug-development company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Seacrown.